Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Cellular immunity and active human cytomegalovirus infection in patients with septic shock.

Cellular immunity and active human cytomegalovirus infection in patients with septic shock. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Cellular immunity and active human cytomegalovirus infection in patients with septic shock. Abstract Text:

    lutz von mullerLutz von Muller,anke klemmAnke Klemm,nilgun durmusNilgun Durmus,manfred weissManfred Weiss,heide suger-wiedeckHeide Suger-Wiedeck,marion schneiderMarion Schneider,walter hamplWalter Hampl,thomas mertensThomas Mertens,lutz von mullerLutz von Muller,anke klemmAnke Klemm,nilgun durmusNilgun Durmus,manfred weissManfred Weiss,heide suger-wiedeckHeide Suger-Wiedeck,marion schneiderMarion Schneider,walter hamplWalter Hampl,thomas mertensThomas Mertens,lutz von mullerLutz von Muller,anke klemmAnke Klemm,nilgun durmusNilgun Durmus,manfred weissManfred Weiss,heide suger-wiedeckHeide Suger-Wiedeck,marion schneiderMarion Schneider,walter hamplWalter Hampl,thomas mertensThomas Mertens,

    BACKGROUND: Human cytomegalovirus (CMV) is an important opportunistic pathogen after transplantations. In the present study, monitoring of CMV in patients with septic shock was used to discover whether T helper cell type 1 (Th1) cell and natural killer (NK) cell functions interact with CMV reactivation in patients not undergoing immunosuppressive therapy. METHODS: Thirty-eight patients with septic shock were monitored, and the 23 CMV-seropositive patients were included in this prospective study. RESULTS: Seven patients (30.4%) developed an active CMV infection despite the detection of CMV-reactive Th1 cells. After active CMV infection, the frequency of CMV-reactive Th1 cells increased from a median of 0.52% to 5.04% (P=.009). Active CMV infections were terminated without antiviral therapy within 2 weeks. In parallel, the frequency of staphylococcal enterotoxin B (SEB; superantigen)-reactive Th1 cells increased from a median of 1.11% to 8.48% (P=.027). In patients without active CMV infection, the frequency of CMV-reactive (median, 0.39%) and SEB-reactive (median, 1.11%) Th1 cells did not increase. Cytotoxic NK cell activity was persistently suppressed despite the presence of CD56(+)CD16(+) NK cells. Moreover, interleukin-2 application in vitro did not restore NK cell activity. CONCLUSIONS: A proinflammatory immune response may contribute to CMV reactivation in patients with septic shock. Adaptive T cell immunity, more likely than NK cell immunity, may contribute to termination of active CMV infection without antiviral therapy in these patients.

    Cellular immunity and active human cytomegalovirus infection in patients with septic shock. Publishing Authors By Initials

    l von mullerL von Muller,a klemmA Klemm,n durmusN Durmus,m weissM Weiss,h suger-wiedeckH Suger-Wiedeck,m schneiderM Schneider,w hamplW Hampl,t mertensT Mertens,l von mullerL von Muller,a klemmA Klemm,n durmusN Durmus,m weissM Weiss,h suger-wiedeckH Suger-Wiedeck,m schneiderM Schneider,w hamplW Hampl,t mertensT Mertens,l von mullerL von Muller,a klemmA Klemm,n durmusN Durmus,m weissM Weiss,h suger-wiedeckH Suger-Wiedeck,m schneiderM Schneider,w hamplW Hampl,t mertensT Mertens,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Cellular immunity and active human cytomegalovirus infection in patients with septic shock. Journal Published:

    PUBLICATION TYPE: Research Support, Non-U.S. Gov

    Journal: The Journal of infectious diseases

    VOLUME: 196

    Page Numbers: 1288-95

    Journal Abbreviation: J. Infect. Dis.

    ISSN: 0022-1899

    DAY: 1

    MONTH: 10

    YEAR: 2007

    Cellular immunity and active human cytomegalovirus infection in patients with septic shock. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 413675

    Cellular immunity and active human cytomegalovirus infection in patients with septic shock. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Cellular immunity and active human cytomegalovirus infection in patients with septic shock. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Cellular immunity and active human cytomegalovirus infection in patients with septic shock.

    AFFILIATION: Institute of Virology, University Hospital Ulm, Ulm, Germany. lutz.mueller@uniklinikum-saarland.de

    Country: United States

    United States Research PublicationUnited States Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: J Infect Dis

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Cellular immunity and active human cytomegalovirus infection in patients with septic shock Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News